Variant report
Variant | nsv947792 |
---|---|
Chromosome Location | chr10:28193069-28196548 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr10:28196308-28196605 | HepG2 | liver: | n/a | chr10:28196462-28196473 chr10:28196463-28196472 |
2 | CEBPB | chr10:28196422-28196551 | K562 | blood: | n/a | chr10:28196462-28196473 chr10:28196463-28196472 |
3 | CEBPB | chr10:28196399-28196599 | Hela-S3 | cervix: | n/a | chr10:28196462-28196473 chr10:28196463-28196472 |
4 | CEBPB | chr10:28196351-28196607 | IMR90 | lung: | n/a | chr10:28196462-28196473 chr10:28196463-28196472 |
5 | CTCF | chr10:28193211-28193276 | Fibrobl | skin: | n/a | n/a |
6 | POLR2A | chr10:28193238-28193285 | A549 | lung: | n/a | n/a |
7 | POLR2A | chr10:28193231-28193236 | A549 | lung: | n/a | n/a |
8 | USF1 | chr10:28196013-28196336 | H1-hESC | embryonic stem cell: | n/a | chr10:28196152-28196163 |
9 | USF1 | chr10:28195988-28196271 | H1-hESC | embryonic stem cell: | n/a | chr10:28196152-28196163 |
10 | USF1 | chr10:28196083-28196224 | HepG2 | liver: | n/a | chr10:28196152-28196163 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:28194965..28197519-chr10:28200097..28202641,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RAB18-5 | chr10:28193138-28193278 | NONHSAT011918 |
2 | lnc-RAB18-5 | chr10:28193928-28194091 | NONHSAT011918 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL36AP55 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192966269 | chr10:28193087-28193088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573109859 | chr10:28193098-28193099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540115299 | chr10:28193134-28193135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562115444 | chr10:28193141-28193142 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs529315469 | chr10:28193166-28193167 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs550944092 | chr10:28193181-28193182 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs182751462 | chr10:28193232-28193233 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs544269082 | chr10:28193242-28193243 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs147832934 | chr10:28193243-28193244 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs552023349 | chr10:28193251-28193252 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs567034272 | chr10:28193255-28193256 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs370340992 | chr10:28193256-28193257 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs549461297 | chr10:28193258-28193259 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs2368274 | chr10:28193276-28193277 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs535141535 | chr10:28193312-28193313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187041250 | chr10:28193383-28193384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575017512 | chr10:28193412-28193413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539113185 | chr10:28193429-28193430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557542781 | chr10:28193441-28193442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150441402 | chr10:28193462-28193463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540418366 | chr10:28193471-28193472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555415070 | chr10:28193483-28193484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573864507 | chr10:28193499-28193500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138218825 | chr10:28193503-28193504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562840020 | chr10:28193536-28193537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191453532 | chr10:28193650-28193651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545476517 | chr10:28193658-28193659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2003191 | chr10:28193659-28193660 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs565441900 | chr10:28193703-28193704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549542021 | chr10:28193761-28193762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567895314 | chr10:28193850-28193851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149577425 | chr10:28193865-28193866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550178122 | chr10:28193880-28193881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568475036 | chr10:28193886-28193887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs880706 | chr10:28193887-28193888 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs557475908 | chr10:28193888-28193889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143244885 | chr10:28193906-28193907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529467364 | chr10:28193990-28193991 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs533780805 | chr10:28193996-28193997 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs183597539 | chr10:28194107-28194108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573872199 | chr10:28194219-28194220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544481259 | chr10:28194343-28194344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200513953 | chr10:28194364-28194365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs578036117 | chr10:28194420-28194421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547840599 | chr10:28194433-28194434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560417869 | chr10:28194439-28194440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527767155 | chr10:28194473-28194474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542877554 | chr10:28194474-28194475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190815571 | chr10:28194481-28194482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531892760 | chr10:28194498-28194499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 21439084 | CNVD |
Maculopathy | 20981449 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 21364760 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 22341455 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:28188400-28214000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr10:28189000-28197800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr10:28195600-28195800 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |
4 | chr10:28195600-28195800 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
5 | chr10:28195800-28203800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr10:28196000-28196400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr10:28196200-28196400 | Enhancers | Fetal Lung | lung |
8 | chr10:28196200-28196600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr10:28196200-28196600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr10:28196200-28196600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr10:28196400-28197000 | Weak transcription | Fetal Lung | lung |
12 | chr10:28196400-28197400 | Enhancers | HepG2 | liver |
13 | chr10:28196400-28199600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |